2016-03-15T00:00:00.000-04:00
business’s revenue,-0.386357
strategic partnerships,0.713315
biotechnology companies,0.555582
life-threatening diseases,-0.363393
DNA delivery technology,-0.58142
Vical Incorporated,0.396382
Ratings Network.com reports,-0.223426
Vical researches,-0.363393
infectious disease vaccines,-0.755268
cardiovascular therapies,-0.331896
DNA delivery technologies,-0.363393
DNA delivery,-0.472407
infectious diseases,-0.58142
DNA vaccines,-0.58142
biopharmaceutical products,-0.363393
InvestorPlace Broker Center,0.555736
major pharmaceutical companies,0.555582
greater resources,0.555582
high fees,-0.735674
12-month high,-0.538672
complementary technologies,0.555582
Zacks Investment Research,0.306163
personal trading style,0.598412
cancer therapeutics,-0.755268
product pipeline,0.713315
Vijay B. Samant,-0.237751
Potential applications,-0.58142
equities research analysts,-0.364834
research offerings,0.40995
average price,0.00892496
consensus estimate,0.215746
cancer immunotherapeutics,-0.424707
concise daily summary,0.510304
stock broker,0.245696
angiogenic growth factor,0.314034
company,-0.139928
mutually beneficial opportunities,0.713315
Vical Incorporated Daily,0.40375
